BioNTech SE (BNTX) Tax Provisions (2018 - 2026)

BioNTech SE has disclosed Tax Provisions across 9 years of filings, most recently posting $44.1 million for Q2 2026.

• In Q2 2026, Tax Provisions rose 141.73% year-over-year to $44.1 million; the TTM figure through Jun 2026 stood at -$66.3 million (down 237.97% YoY), while the FY2025 annual figure was $99.3 million, up 849.35% from the prior year.
• Tax Provisions came in at $44.1 million for Q2 2026 at BioNTech SE, up from $42.4 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $241.5 million in Q2 2023 to a low of -$1.5 billion in Q1 2022.
• Average Tax Provisions over 5 years is -$223.5 million, with a median of -$53.5 million recorded in 2024.
• The largest YoY upside for Tax Provisions was 946.17% in 2025 against a maximum downside of 244.27% in 2025.
• Over 5 years, Tax Provisions stood at -$912.0 million in 2022, then surged by 75.78% to -$220.9 million in 2023, then soared by 79.83% to -$44.6 million in 2024, then tumbled by 102.71% to -$90.3 million in 2025, then jumped by 148.77% to $44.1 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $44.1 million in Q2 2026, $42.4 million in Q1 2026, and -$90.3 million in Q4 2025.